• 2018 consensus of the Taiwan Society of Cardiology and the Diabetes Association
  of Republic of China (Taiwan) on the pharmacological management of patients with 
  type 2 diabetes and cardiovascular diseases
• Atrial Fibrillation (2016)
• Hypertension(2017)
• Hypertension (2015)
• Hypertension(2010)
• ST-Segmant Elevation Myocardial Infarction (2012)
• Diagnosis and Treatment of Heart Failure (2012)
• 2018 TSOC guideline focused update on diagnosis and treatment of pulmonary arterial hypertension
• 台灣心胸共病共識手冊(2019)
• 2019 Focused Update of the Guidelines of the TSOC for the Diagnosis and Treatment of Heart Failure
• TSOC DM consensus (2020)
• Management of ACS in Patients with Suspected or Confirmed COVID-19:
  Consensus from TSOC (2020)
• 2020 Focused Update of the 2012 Guidelines of the TSOC for the Management of ST-Segment Elevation Myocardial Infarction
• 2020 Consensus of Taiwan Society of Cardiology on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases
• 2021 Advocacy Statements for the Role of ^99mTc-Pyrophosphate Scintigraphy in the Diagnosis of Transthyretin Cardiac Amyloidosis: A Report of the Taiwan Society of Cardiology and the Society of Nuclear Medicine of the Republic of China
• 2021 TSOC Expert Consensus on the Clinical Features, Diagnosis, and Clinical Management of Cardiac Manifestations of Fabry Disease
• 2021 Consensus Pathway of the Taiwan Society of Cardiology on Novel Therapy for Type 2 Diabetes
• Risk Management for Radiation-Induced Cardiovascular Disease (RICVD): The 2022 Consensus Statement of the Taiwan Society for Therapeutic Radiology and Oncology (TASTRO) and Taiwan Society of Cardiology (TSOC) (2022)
• 2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension - A Report of the Task Force of the Hypertension Committee and the Guideline Committee of the Taiwan Society of Cardiology and the Taiwan Hypertension Society (2022)